[1] He S, Chen M, Wu W,et al. An emerging and expanding clade accounts for the persistent outbreak of Coxsackievirus A6-associated hand, foot, and mouth disease in China since 2013[J].Virology,2018, 518: 328-334. [2] 钱素云,李兴旺.我国手足口病流行及诊治进展十年回首[J].中华儿科杂志,2018, 56(5): 321-323. [3] Koh WM,Badaruddin H,La H,et al.Severity and burden of hand, foot and mouth disease in Asia: a modelling study[J].BMJ Glob Health,2018, 3(1): e000442. [4] 吴香苓.早期应用甘露醇联合甲强龙治疗60例重症小儿手足口病临床疗效观察[J].中国医学工程,2015,23(4):150-151. [5] Hu X, Jiang F, Ni W. Floods increase the risks of hand-foot-mouth disease in Qingdao, China, 2009-2013: a quantitative analysis[J].Disaster Med Public Health Prep,2018,8:1-7. [6] Zhao Q, Li S, Cao W,et al.Modeling the present and future incidence of pediatric hand, foot, and mouth disease associated with ambient temperature in mainland China[J].Environ Health Perspect,2018, 126(4): 047010. [7] Lim H.The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease[J]. Vaccine,2018,36(24):3445-3452. [8] Gao L, Zou G, Liao Q,et al.Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples[J].Clin Infect Dis,2018,67(11):1729-1735. [9] 支燕芳.甘露醇联合地塞米松治疗早期重症手足口病的效果评价[J].中西医结合心血管病电子杂志 ,2017,5(8):96. [10] 郑吉祥.丙种球蛋白及干扰素治疗手足口病合并病毒性脑炎的临床疗效观察[J].世界临床医学, 2016,10 (24) :168-170.
2018, Vol. 35 
